Menu
GeneBe

rs281865489

Variant summary

Our verdict is Pathogenic. Variant got 11 ACMG points: 12P and 1B. PM1PM2PP5_Very_StrongBP4

The NM_004614.5(TK2):c.268C>T(p.Arg90Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000867 in 1,613,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000089 ( 0 hom. )

Consequence

TK2
NM_004614.5 missense

Scores

2
6
9

Clinical Significance

Likely pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 3.67
Variant links:
Genes affected
TK2 (HGNC:11831): (thymidine kinase 2) This gene encodes a deoxyribonucleoside kinase that specifically phosphorylates thymidine, deoxycytidine, and deoxyuridine. The encoded enzyme localizes to the mitochondria and is required for mitochondrial DNA synthesis. Mutations in this gene are associated with a myopathic form of mitochondrial DNA depletion syndrome. Alternate splicing results in multiple transcript variants encoding distinct isoforms, some of which lack transit peptide, so are not localized to mitochondria. [provided by RefSeq, Dec 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 11 ACMG points.

PM1
In a chain Thymidine kinase 2, mitochondrial (size 231) in uniprot entity KITM_HUMAN there are 48 pathogenic changes around while only 6 benign (89%) in NM_004614.5
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-66536981-G-A is Pathogenic according to our data. Variant chr16-66536981-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 38982.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-66536981-G-A is described in Lovd as [Likely_pathogenic].
BP4
Computational evidence support a benign effect (MetaRNN=0.2419571).. Strength limited to SUPPORTING due to the PP5.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TK2NM_004614.5 linkuse as main transcriptc.268C>T p.Arg90Cys missense_variant 4/10 ENST00000544898.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TK2ENST00000544898.6 linkuse as main transcriptc.268C>T p.Arg90Cys missense_variant 4/101 NM_004614.5 P1O00142-1

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152002
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000945
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000119
AC:
3
AN:
251486
Hom.:
0
AF XY:
0.00000736
AC XY:
1
AN XY:
135918
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000889
AC:
13
AN:
1461886
Hom.:
0
Cov.:
31
AF XY:
0.00000963
AC XY:
7
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.000131
Gnomad4 NFE exome
AF:
0.00000360
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
152002
Hom.:
0
Cov.:
31
AF XY:
0.0000135
AC XY:
1
AN XY:
74234
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000945
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2023TK2: PM3:Strong, PM2, PP4:Moderate -
Likely pathogenic, criteria provided, single submitterclinical testingGeneDxMar 17, 2022Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25215937, 22345218, 31589614, 28217183, 29602790) -
Mitochondrial DNA depletion syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpDec 11, 2023Variant summary: TK2 c.268C>T (p.Arg90Cys) results in a non-conservative amino acid change located in the Deoxynucleoside kinase domain (IPR031314) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251486 control chromosomes (gnomAD). c.268C>T has been reported in the literature in individuals affected with Mitochondrial DNA Depletion Syndrome - TK2 Related who were compound heterozygous with other pathogenic variants (Behin_2012, Dominguez-Gonzalez_2019). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22345218, 31125140, 26224072). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Mitochondrial DNA depletion syndrome, myopathic form Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMFeb 28, 2012- -
Myopathy Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingNeurologia y Psiquiatria, Clinica Alemana SantiagoJul 15, 2022We report a 50-year-old female with recurrent rhabdomyolysis, bilateral ptosis, and girdle limb weakness. Muscle biopsy presented frequent, red-raged fibers and dystrophic changes. The most severely affected muscles in magnetic resonance imaging (MRI) axial T1-weighted sequences were the gluteus maximus, sartorius and tensor fasciae latae muscles. We found a compound heterozygous mutation in TK2-gene (pathogenic mutation in [c.323C>T p.(Thr108Met)] and novel mutation in [c.268C>T p.(Arg90Cys)]). Deoxynucleoside therapy was offered. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Uncertain
0.090
Cadd
Pathogenic
27
Dann
Uncertain
0.99
DEOGEN2
Pathogenic
0.89
D;D;.;.;.;D
Eigen
Benign
-0.070
Eigen_PC
Benign
0.085
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.94
D;.;D;D;D;D
M_CAP
Benign
0.047
D
MetaRNN
Benign
0.24
T;T;T;T;T;T
MetaSVM
Uncertain
0.031
D
MutationAssessor
Benign
1.8
L;L;.;.;.;.
MutationTaster
Benign
0.99
D;D;D;D;D;D;D;D;D;D
PrimateAI
Benign
0.40
T
REVEL
Uncertain
0.60
Sift4G
Benign
0.12
T;T;T;T;T;T
Polyphen
0.023
.;.;.;B;.;.
Vest4
0.30
MutPred
0.56
.;.;Loss of MoRF binding (P = 0.0355);.;.;.;
MVP
0.98
MPC
0.49
ClinPred
0.88
D
GERP RS
4.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.13
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs281865489; hg19: chr16-66570884; API